Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

California bill

This article was originally published in The Tan Sheet

Executive Summary

Measure that would prohibit sale of supplements containing ephedrine alkaloids, creatine, andro, DHEA or pregnenolone to children under 18, require specific label warnings set for Senate approps committee hearing May 13. SB 1750, introduced by Sen. Jackie Speier (D), passed HHS committee April 25 by 7-1 vote, despite opposition from industry groups including CHPA, NNFA, EEC, who claim bill would impose unnecessary, burdensome requirements on marketers. Separate Speier bill (SB 1562) passed education committee April 30 by 11-0 count, also will be heard by approps committee May 13. Measure, which faces no industry resistance, would require school districts to educate grades 7-12 on effects of performance enhancing substances, weight-loss products (1"The Tan Sheet" March 11, 2002, p. 10)...

You may also be interested in...



Sport Supplement High School Education Program Urged In California Bill

All secondary schools in California would be required to instruct students on the effects of performance-enhancing substances under a state bill recently introduced by Sen. Jackie Speier (D)

Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line

The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.

Global Pharma Guidance Tracker – March 2024

Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS093985

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel